Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.

Monia Marchetti, Giovanni Barosi, Francesca Balestri, Gianluca Viarengo, Sara Gentili, Sara Barulli, Jean-Loup Demory, Fiorella Ilariucci, Antonio Volpe, Dominique Bordessoule, Marie Caroline Le Bousse-Kerdiles, Andrea Caenazzo, Alessandro Pecci, Antonietta Falcone, Giorgio Broccia, Cesarina Bendotti, Fredric Bauduer, Francesco Buccisano, Brigitte Dupriez

115 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences